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Abstract 
CD97 is a member of a new subgroup of seven-span transmembrane (7-TM) molecules which belong to the secretin receptor 
superfamily. Different from other members of the secretin receptor family, these recently characterized molecules have extended 
extracellular regions comprising several EGF domains near the NH 2 terminus. We recently demonstrated that the extracellular 
part of CD97 is involved in intercellular adhesion since it specifically binds to CD55 (decay accelerating factor), a regulatory 
protein of the complement cascade. To our knowledge this is the first demonstration of a cellular ligand for a 7-TM molecule. 
© 1996 Elsevier Science B.V. All rights reserved 
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1. Secretin receptor superfamily 
Seven-span transmembrane molecules (7-TM) form 
one of the largest superfamilies of  cell surface proteins 
with more than 100 members described by their pri- 
mary structure so far [1]. A common feature of  these 
receptors is their association with G proteins which 
engage signalling pathways leading to an increase of  
cAMP and/or the mobilization of  intracellular Ca + ÷ 
[2]. Besides light-induced conformational changes in 
visual pigments, different types of  molecules, e.g. 
cationic amines, arachidonic acid derivates, peptides 
and glycoprotein hormones can ligate 7-TM receptors. 
Molecular cloning of  the secretin receptor by Ishi- 
hara et al. (1991) has revealed a sequence pattern of  the 
membrane-spanning region different from that of  clas- 
sical 7-TM molecules [3]. Meanwhile, a number of  
homologous receptors have been described which bind 
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mammalian and insect peptide hormones, e.g. calci- 
tonin, parathyroid hormone, vasoactive intestinal pep- 
tide, glucagon-like peptide 1, glucagon, pituitary 
adenylate cyclase-activating polypeptide, corticotropin- 
releasing factor and insect diuretic hormone [4]. 
2. 7-TM receptors with extended extracellular domains 
The recent cDNA cloning of  CD97 [5], EMRI [6] 
and F4/80 [7] has shown that the secretin receptor 
group displays additional diversity. Their transmem- 
brane region clearly places these molecules into the 
SecR group (20-25% amino acid (aa) identity). How- 
ever, the extracellular parts of CD97, EMRI and F4/80 
exceed that from known members of the SecR super- 
family (about 150 aa) and are characterized by several 
E G F  domains near to the N-terminus. 
The large similarity of  CD97 and EMRI (30.6% 
identity in 703 aa) as well as the assignment of the 
encoding genes to the same region on the short arm of 
human chromosome 19 [5,6] suggests a common pre- 
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cursor gene that has probably evolved from the SeeR 
supergene family. Analysis of  the organization of the 
CD97 gene has confirmed this assumption and demon- 
strated that the precursor gene has assembled the N-ter- 
minal E G F  domains by exon shuffling [8]. 
3. CD97 has a cellular ligand: CD55 
The most  relevant question to be answered is whether 
the acquisition of  E G F  domains has provided this new 
class of  7-TM receptors with novel functional proper- 
ties. Indeed, by demonstrating that lymphocytes and 
erythrocytes specifically adhere to CD97-transfected 
COS cells we found that CD97, in parallel with its 
molecular evolution, has acquired the ability to bind 
cellular ligands. This interaction was found to be spe- 
cific since it could be blocked by CD97 mAb (Table 1) 
[9]. 
To identify the cellular ligand for CD97 a mouse was 
immunized with human red cells, and spleen cells were 
fused with SP2/0. Hybr idoma supernatants were 
screened for their ability to block the binding erythro- 
cytes to CD97 transfectants and one mAb, designated 
CLB-CD97L, was selected in this way. Initial character- 
ization of the mAb showed that it reacted with both 
leukocytes and red cells. Moreover,  biochemical analy- 
sis showed that the antibody recognized a membrane 
glycoprotein with a molecular mass of  70 kD. Among 
antigens of  this size characterized until know only a 
small number  are expressed on both leukocytes and red 
cells. When we tested the capacity of  mAbs against 
these molecules to inhibit the binding between CD97- 
transfectants and erythrocytes only antibodies directed 
against CD55 turned out to be inhibitory (Table 1). 
CD55 is a GPI-anchored molecule that by inhibiting 
C3/C5 convertases protects cells from complement-me- 
Table 1 
CD55 mAb inhibit the binding of 5~Cr-labeled erythrocytes to CD97- 
transfected COS cells 
Antibody CD55 SCR-domain Adhesion (%)a 
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Fig. 1. Schematic representation of the interaction between CD97 and 
CD55. 
diated damage [10]. CD55 is built f rom four so called 
'short  consensus repeat '  (SCR) domains. The ability to 
dissociate and prevent assembly of C3/C5 convertases 
has been mapped to SCR-2, 3 and 4. In addition, 
Echovirus 7 also requires SCR-2, 3, and 4 for binding 
to CD55 [11] whereas E. coli  Dr Adhesin recognizes 
SCR-3 [12]. Using mAb to distinct SCR we found that 
mAb to SCR-1, 2 and 3 can block the interaction 
between CD97 and CD55 (Fig. 1) implying for the first 
time a role for SCR-1 in ligand binding. Finally, the 
specificity of  the interaction between CD97 and CD55 
was confirmed by the finding that red cells that do not 
express CD55 do not adhere to CD97 transfectants [9]. 
4. Conclusions 
CD97 is a 7-TM molecule that is rapidly up-regu- 
lated on leukocytes after activation [5,13]. Remarkably,  
among the hundreds of  known 7-TM molecules CD97 
is the first receptor for which a cellular ligand has been 
demonstrated [1]. The interaction between CD97 and 
CD55 implies the existence of  a novel adhesion path- 
way primarily used by stimulated but not resting leuko- 
cytes. The signalling and functional consequences of  
this interaction are currently under investigation. 
None n.a. b 100 
Control (IgG1) n.a. 103 
CLB-CD97/1 n.a. 13 
CLB-CD97L/I 1 8 
BRIC220 1 33 
BRIC230 1 77 
BRIC110 2 24 
BRIC216 3 16 
Results are expressed as the percentage of erythrocyte binding relative 
to the amount bound in the absence of mAb. For experimental details 
see [9]. 
aBinding of erythrocytes to CD97 transfectants: in the absence of 
antibodies was set at 100%. 
bNot applicable. 
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